ClinicalTrials.Veeva

Menu

Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)

U

University of Calgary

Status

Enrolling

Conditions

Length of Stay

Treatments

Other: Standardized care bundle- nutritional care
Behavioral: QI mentoring
Behavioral: Collaborative networking
Other: Standardized care bundle- respiratory care
Behavioral: QI education
Behavioral: QI Team Building
Other: Current practice- standard of care

Study type

Interventional

Funder types

Other

Identifiers

NCT05231200
462647 (Other Grant/Funding Number)
21-1336

Details and patient eligibility

About

The ABC-QI Trial aims to implement collaborative quality improvement (QI) strategies to standardize care for 32-36 week infants in Level 2 and 3 Neonatal intensive care units (NICUs) across the province of Alberta. The investigators want to know if using validated quality improvement methods and evidence-based care bundles will decrease the duration of hospital stay and get babies home as quickly as possible.

Full description

A stepped-wedge cluster randomized trial will be conducted in 12 NICUs across Alberta (10 Level II and 2 Level III). Each NICU is considered a cluster and will be randomized to transition to the intervention arm at one of three time points.

The planned trial interventions include:

Intervention arm (Collaborative QI Strategies): The study intervention is a constellation of collaborative QI strategies: 1) QI Team Building; 2) QI Education; 3) Implementation of 2 standardized practice care bundles (Respiratory Care, and Nutritional Care); 4) QI mentoring; and 5) Collaborative networking. Based on the randomization, 4 NICUs will transition to the intervention arm at the end of each year.

Control arm (current management): All participating NICUs will be in the control arm during the first year prior to randomization to create a baseline of the current practices and between-units variation. NICUs in the control arm can continue conducting QI activities relevant to current practice, but without receiving the interventions outlined above.

Enrollment

9,500 estimated patients

Sex

All

Ages

32 to 36 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

Preterm Infants: Infants born at 32 to 36 weeks' gestation and admitted to the participating NICUs or postpartum units.

Quality Improvement Implementation Survey version 2 (QIIS-II) and semi-structured interview participants: Management staff, nurses, nurse practitioners, physicians, and allied health staff employed in participating NICUs.

Exclusion criteria

  • Preterm Infants:

    • Major congenital anomalies or chromosomal abnormalities.
    • Primary admission to a surgical NICU: Alberta Children's Hospital or Stollery Children's Hospital.
    • Infants born in or transferred to a NICU outside Alberta.
    • Patients who have imposed confidentiality restrictions on accessing their health records.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

9,500 participants in 2 patient groups

Control Arm- Current management
Active Comparator group
Description:
NICUs in the control arm can continue conducting QI activities relevant to current practice and current standard of care, but without receiving the interventions until they transition to the intervention arm.
Treatment:
Other: Current practice- standard of care
Intervention Arm- Collaborative Quality implementation Strategies
Experimental group
Description:
The study intervention is a constellation of collaborative QI strategies: 1) QI Team Building; 2) QI Education; 3) Implementation of 2 standardized practice care bundles (Respiratory Care, and Nutritional Care); 4) QI mentoring; and 5) Collaborative networking.
Treatment:
Behavioral: QI Team Building
Behavioral: QI education
Behavioral: Collaborative networking
Other: Standardized care bundle- respiratory care
Behavioral: QI mentoring
Other: Standardized care bundle- nutritional care

Trial contacts and locations

12

Loading...

Central trial contact

Mahesha Bandara, MSc; Ayman Abou Mehrem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems